ChemicalBook > Product Catalog >API >Antibiotics >Cephalosporins Drugs >Cefpodoxime proxetil

Cefpodoxime proxetil

Cefpodoxime proxetil  Structure
CAS No.
87239-81-4
Chemical Name:
Cefpodoxime proxetil
Synonyms
VANTIN;Cefodoxime Proxetil;BANAN;cefpodoxime axetil;CS-807;OTREON;ORELOX;JP,USP;R-3763;U-76253
CBNumber:
CB5150483
Molecular Formula:
C21H27N5O9S2
Molecular Weight:
557.6
MOL File:
87239-81-4.mol
MSDS File:
SDS
Modify Date:
2024/7/2 8:55:10

Cefpodoxime proxetil Properties

Melting point 111-113°C
Density 1.58±0.1 g/cm3(Predicted)
RTECS XI0367370
storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility Soluble in DMSO
form Solid
pka 8.13±0.60(Predicted)
color White to Pale Yellow
Sensitive Light Sensitive
InChIKey LTINZAODLRIQIX-FBXRGJNPSA-N
SMILES N12[C@@]([H])([C@H](NC(/C(/C3=CSC(N)=N3)=N\OC)=O)C1=O)SCC(COC)=C2C(OC(OC(OC(C)C)=O)C)=O
CAS DataBase Reference 87239-81-4(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS08
Signal word  Warning
Hazard statements  H317-H334
Precautionary statements  P261-P280g-P284-P304+P340-P342+P311a-P501a
Hazard Codes  Xi
Risk Statements  36/37/38-42/43
Safety Statements  22-26-36/37/39
WGK Germany  3
HS Code  30042000
Toxicity LD50 in male, female mice, male, female rats (mg/kg): >10000, >10000, >2000, >2000 s.c., 3502, 2535, >4000, >4000 i.p.; >8000, >8000, >4000, >4000 orally (Nakao, 1988)

Cefpodoxime proxetil price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) A3987 Cefpodoxime proxetil 87239-81-4 50MG ₹47121.23 2022-06-14 Buy
Product number Packaging Price Buy
A3987 50MG ₹47121.23 Buy

Cefpodoxime proxetil Chemical Properties,Uses,Production

Description

Cefpodoxime proxetil is an orally active, broad-spectrum cephalosporin especially useful in the treatment of bacterial infections in children. It is a prodrug converted by esterases in the GI walls to cefpodoxime, which reportedly has a bacteriostatic spectrum comparable to injectable third-generation cephem antibiotics.

Chemical Properties

Pale Yellow Solid

Uses

A broad spectrum antibiotic. Cefpodoxime proxetil is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against gram positive and gram negative microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options for infected patients. Product is to be used for research and development only.

Definition

ChEBI: The 1-[(isopropoxycarbonyl)oxy]ethyl (proxetil) ester prodrug of cefpodoxime. After swallowing, hydrolysis of the ester group occurs in the intestinal epithelium, to release active cefpodoxime in the bloodstream. It is used to treat acute otitis media, pha yngitis, and sinusitis.

Clinical Use

Cefpodoxime proxetil (Vantin) is the isopropyloxycarbonylethylester of the third-generation cephalosporincefpodoxime. This orally active prodrug derivative is hydrolyzedby esterases in the intestinal wall and in theplasma to provide cefpodoxime. Tablets and a powder forthe preparation of an aqueous suspension for oral pediatricadministration are available. The oral bioavailability of cefpodoximefrom the proxetil is estimated to be about 50%.Administration of the prodrug with food enhances its absorption.The plasma half-life is 2.2 hours, which permitsadministration on a twice-daily schedule.
Cefpodoxime is a broad-spectrum cephalosporin withuseful activity against a relatively wide range of Grampositiveand Gram-negative bacteria. It is also resistant tomany β-lactamases. Its spectrum of activity includes S.pneumoniae, Streptococcus pyogenes, S. aureus, H. influenzae,M. catarrhalis, and Neisseria spp. Cefpodoxime is alsoactive against members of the Enterobacteriaceae family,including E. coli, K. pneumoniae, and P. mirabilis. It thusfinds use in the treatment of upper and lower respiratory infections,such as pharyngitis, bronchitis, otitis media, andcommunity-acquired pneumonia. It is also useful for thetreatment of uncomplicated gonorrhea.

Side effects

Common side effects of Cefpodoxime proxetil include: headache, nausea, vomiting, diarrhoea, stomach pain, insomnia, vaginal swelling, redness, irritation, burning or itching. Severe may include: rash, itching, measles, difficulty breathing or swallowing, fever, sore throat, chills, or other signs of an infection coming back; swollen ankles or feet, dark urine, yellowing of the skin, easy bruising or bleeding, kidney problems. Seek medical attention if you have a serious adverse reaction.

Global( 394)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
CHEMXTREE STANDARDS +919872732255 Punjab, India 96 58 Inquiry
Aurobindo Pharma Limited +914066725000 Telangana, India 112 58 Inquiry
Hetero Drugs Limited +91-4023704923 +91-4023704923 Telangana, India 296 58 Inquiry
Sun Pharmaceutical Industries Ltd +91-2242244224 +91-2243244324 Maharashtra, India 108 58 Inquiry
Nectar Lifesciences Ltd +91-9357244445 +91-9357244445 Punjab, India 29 58 Inquiry
HRV Global Life Sciences +91-9820219686 +91-9820219686 Telangana, India 379 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Alfa Omega Pharma +91-8050045945 +91-9972665399 Maharashtra, India 126 58 Inquiry
Suvan LifeSciences (formerly Sansh Biotech Pvt Ltd) +91-1142631798 +91-9899000024 New Delhi, India 55 58 Inquiry
Covalent Laboratories Private Limited (Virchow Group) +91-4049483333 +91-9866077161 Telangana, India 9 58 Inquiry

Related articles

Cefpodoxime proxetil Spectrum

(RS)-1(ISOPROPOXYCARBONYLOXY)ETHYL (+)-(6R,7R)-7-[2-(2-AMINO-4-THIAZOLYL)-2-[(Z)METHOXYIMINO]ACETAMIDO]-3-METHOXYMETHYL-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE ORELOX OTREON U-76252 U-76253 (6r-(6-alpha,7-beta(z)))-bonyl)oxy)ethyleste 1-(((1-methylethoxy)car (+)-(6R,7R)-7-[2-(2-AMINO-4-THIAZOLYL)-2-[(Z)METHOXYIMINO]ACETAMIDO]-3-METHOXYMETHYL-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE CS-807 CEFODOX CEFPODOXIME PROXETIL Cefpodoxime Proxetil JPFa CefpodoximeProxet Cefopodoximeproxetil JP,USP CS-807, U-76252, Banan, Cefodox, Orelox, Otreon, Vantin (RS)-1-(Isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-[(Z)-(methoxyimino]acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, [6R-[6α,7β(Z)]]- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-, 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)- Antibiotic CS 807 Cephpodoxime proxetil CS 807 (pharmaceutical) RU 51807 Cefpodoxime Proxetil, Vantin, (RS)-1(isopropoxycarbonyloxy)ethyI (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-{(Z)methoxyimino}acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Cefpodoxime-d3, Free Acid Orelox:Otreon (6R,6β)-7α-[[(2-Aminothiazol-4-yl)[(Z)-(methoxy)imino]acetyl]amino]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-(isopropoxycarbonyloxy)ethyl ester Cefpodoxime Proxetil (350 mg) A spore anchors wo ester (6R,7R)-7-[(2Z)-2-(2-aMino-1,3-thiazol-4-yl)-2-(MethoxyiMino)acetaMido]-3-(MethoxyMethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(2Z)-2-(2-AMino-4-thiazolyl)-2-(MethoxyiMino-d3)acetyl]aMino]-3-(MethoxyMethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid CefpodoxiMe-d3 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-2-(2-aMino-4-thiazolyl)-2-(MethoxyiMino)acetyl]aMino]-3-(MethoxyMethyl)-8-oxo-,1-[[(1-Methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)- Cefpodoxime proxetil for peak identification Cefpodoxime proxetil for impurity H identification cefpodoxime proxetil IMP IMP R-3763 Cefpodoxime, Free Acid (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 7-[[2-methoxyimino-2-(2-methyl-4-thiazolyl)-1-oxoethyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[oxo(propan-2-yloxy)methoxy]ethyl ester Cefpodoxime Proxetil (Mixture of Diastereomers) Cefpodoxime Proxetil Impurity Cefpodoxime proxetil CRS Cefpodoxime proxetil for peak identification CRS Cefpodoxime proxetil for impurity H identification CRS Cefpodoxime proxetil USP/EP/BP (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester (6R,7R)-1-((Isopropoxycarbonyl)oxy)ethyl 7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Cefpodoxime Proxetil (Mixture Of Isomers)Q: What is Cefpodoxime Proxetil (Mixture Of Isomers) Q: What is the CAS Number of Cefpodoxime Proxetil (Mixture Of Isomers) Q: What is the storage condition of Cefpodoxime Proxetil (Mixture Of Isomers) Q: What are the applications of Cefpodoxime Proxetil (Mixture Of Isomers) Cefpodoxime proxetil (Y0001305)Q: What is Cefpodoxime proxetil (Y0001305) Q: What is the CAS Number of Cefpodoxime proxetil (Y0001305) Q: What are the applications of Cefpodoxime proxetil (Y0001305) Cefpodoxime Proxetil (1098027) VANTIN BANAN Cefodoxime Proxetil cefpodoxime axetil Cefpoxime ester Cefpodoxime proxeti (1 RS )-1-[(1-Methylethoxy)carbonyloxy]ethyl (6 R ,7 R )-7-[( Z )-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetylamino]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate